| Application no. and date | 06755779.3 (espacenet) (Federated) (European Patent Register), 20060717 | | Patent/reg. no. and date | DK/EP 1904490, 20100929 | | Publication date | 20080402 | | Priority no. and date | GB 0514743, 20050719 | | EP pub. no. and date |
EP 1904490 20080402 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST 101930-1XEP | | Inventor | HOGAN, Phillip John, AstraZeneca
Charter Way
Macclesfield Cheshire SK10 2NA, GB,
MONTGOMERY, Frank, AstraZeneca
Charter Way
Macclesfield Cheshire SK10 4TG, GB,
GOOD, Catherine, AstraZeneca R & D Alderley
Alderley Park
Macclesfield Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/497 (2006.01) , A61P 35/04 (2006.01) , C07D 413/14 (2006.01) | | Title | Ethanolaminsalt af N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridin-3-sulfonamid | | Int. application no. | GB2006002654 | | Int. publication no. | WO2007010235 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
